WO2000059491A3 - Methods for modulating the human sexual response - Google Patents
Methods for modulating the human sexual response Download PDFInfo
- Publication number
- WO2000059491A3 WO2000059491A3 PCT/US2000/009112 US0009112W WO0059491A3 WO 2000059491 A3 WO2000059491 A3 WO 2000059491A3 US 0009112 W US0009112 W US 0009112W WO 0059491 A3 WO0059491 A3 WO 0059491A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- modulating
- sexual response
- methods
- phentolamine
- human sexual
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/417—Imidazole-alkylamines, e.g. histamine, phentolamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
Abstract
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000609055A JP2002541100A (en) | 1999-04-06 | 2000-04-06 | Methods for modulating human sexual response |
MXPA01010021A MXPA01010021A (en) | 1999-04-06 | 2000-04-06 | Methods for modulating the human sexual response. |
EP00921760A EP1220666A2 (en) | 1999-04-06 | 2000-04-06 | Methods for modulating the human sexual response |
KR1020017012674A KR20020015310A (en) | 1999-04-06 | 2000-04-06 | Methods for modulating the human sexual response |
AU42036/00A AU4203600A (en) | 1999-04-06 | 2000-04-06 | Methods for modulating the human sexual response |
CA002366903A CA2366903A1 (en) | 1999-04-06 | 2000-04-06 | Methods for modulating the human sexual response |
BR0009583-4A BR0009583A (en) | 1999-04-06 | 2000-04-06 | Methods to modulate the sexual response in a human, and for the manufacture of a drug to modulate the sexual response in a human |
NO20014827A NO20014827L (en) | 1999-04-06 | 2001-10-04 | Procedures for modulating human sexual response |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12791099P | 1999-04-06 | 1999-04-06 | |
US60/127,910 | 1999-04-06 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000059491A2 WO2000059491A2 (en) | 2000-10-12 |
WO2000059491A3 true WO2000059491A3 (en) | 2002-05-02 |
Family
ID=22432589
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/009112 WO2000059491A2 (en) | 1999-04-06 | 2000-04-06 | Methods for modulating the human sexual response |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1220666A2 (en) |
JP (1) | JP2002541100A (en) |
KR (1) | KR20020015310A (en) |
CN (1) | CN1374861A (en) |
AU (1) | AU4203600A (en) |
BR (1) | BR0009583A (en) |
CA (1) | CA2366903A1 (en) |
MX (1) | MXPA01010021A (en) |
NO (1) | NO20014827L (en) |
WO (1) | WO2000059491A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0130704D0 (en) * | 2001-12-21 | 2002-02-06 | Glaxo Group Ltd | New use |
US8939889B1 (en) | 2013-08-22 | 2015-01-27 | Coloplast A/S | Pump bulb for an implantable penile prosthetic |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0346297A1 (en) * | 1988-06-08 | 1989-12-13 | CENTRO MEDICO HARVEY S.r.l. | A preparation for topical use in the therapeutic treatment of impotentia coeundi |
WO1995005172A1 (en) * | 1993-08-13 | 1995-02-23 | Zonagen, Inc. | Methods for modulating the human sexual response |
WO1998043614A1 (en) * | 1997-03-28 | 1998-10-08 | Lam Pharmaceuticals, Llc | Drug preparations for treating sexual dysfunction |
WO1998052569A1 (en) * | 1997-05-19 | 1998-11-26 | Zonagen, Inc. | Combination therapy for modulating the human sexual response |
WO1999027905A1 (en) * | 1997-12-02 | 1999-06-10 | West Pharmaceutical Services Drug Delivery & Clinical Research Centre Limited | Compositions for nasal administration |
US5981563A (en) * | 1995-04-28 | 1999-11-09 | Zonagen, Inc. | Methods and formulations for modulating the human sexual response |
WO1999065475A2 (en) * | 1998-06-19 | 1999-12-23 | Schering Corporation | Combination of phentolamine and apomorphine for the treatment of human sexual function and dysfunction |
WO2000013664A1 (en) * | 1998-09-08 | 2000-03-16 | L.A.M. Pharmaceutical Corp | Drug preparations for treating sexual dysfunction |
WO2000033825A2 (en) * | 1998-12-10 | 2000-06-15 | Nexmed Holdings, Inc. | Compositions and methods for amelioration of human female sexual dysfunction |
-
2000
- 2000-04-06 JP JP2000609055A patent/JP2002541100A/en not_active Withdrawn
- 2000-04-06 BR BR0009583-4A patent/BR0009583A/en not_active Application Discontinuation
- 2000-04-06 KR KR1020017012674A patent/KR20020015310A/en not_active Application Discontinuation
- 2000-04-06 CA CA002366903A patent/CA2366903A1/en not_active Abandoned
- 2000-04-06 AU AU42036/00A patent/AU4203600A/en not_active Abandoned
- 2000-04-06 WO PCT/US2000/009112 patent/WO2000059491A2/en not_active Application Discontinuation
- 2000-04-06 CN CN00807879A patent/CN1374861A/en active Pending
- 2000-04-06 EP EP00921760A patent/EP1220666A2/en not_active Withdrawn
- 2000-04-06 MX MXPA01010021A patent/MXPA01010021A/en unknown
-
2001
- 2001-10-04 NO NO20014827A patent/NO20014827L/en not_active Application Discontinuation
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0346297A1 (en) * | 1988-06-08 | 1989-12-13 | CENTRO MEDICO HARVEY S.r.l. | A preparation for topical use in the therapeutic treatment of impotentia coeundi |
WO1995005172A1 (en) * | 1993-08-13 | 1995-02-23 | Zonagen, Inc. | Methods for modulating the human sexual response |
US5981563A (en) * | 1995-04-28 | 1999-11-09 | Zonagen, Inc. | Methods and formulations for modulating the human sexual response |
WO1998043614A1 (en) * | 1997-03-28 | 1998-10-08 | Lam Pharmaceuticals, Llc | Drug preparations for treating sexual dysfunction |
WO1998052569A1 (en) * | 1997-05-19 | 1998-11-26 | Zonagen, Inc. | Combination therapy for modulating the human sexual response |
WO1999027905A1 (en) * | 1997-12-02 | 1999-06-10 | West Pharmaceutical Services Drug Delivery & Clinical Research Centre Limited | Compositions for nasal administration |
WO1999065475A2 (en) * | 1998-06-19 | 1999-12-23 | Schering Corporation | Combination of phentolamine and apomorphine for the treatment of human sexual function and dysfunction |
WO2000013664A1 (en) * | 1998-09-08 | 2000-03-16 | L.A.M. Pharmaceutical Corp | Drug preparations for treating sexual dysfunction |
WO2000033825A2 (en) * | 1998-12-10 | 2000-06-15 | Nexmed Holdings, Inc. | Compositions and methods for amelioration of human female sexual dysfunction |
Non-Patent Citations (5)
Title |
---|
BERMAN J R ET AL: "FEMALE SEXUAL DYSFUNCTION: INCIDENCE, PATHOPHYSIOLOGY, EVALUATION, AND TREATMENT OPTIONS", UROLOGY,US,BELLE MEAD, NJ, vol. 54, September 1999 (1999-09-01), pages 385 - 391, XP000891790, ISSN: 0090-4295 * |
GOLDSTEIN I ET AL: "VASCULOGENIC FEMALE SEXUAL DYSFUNCTION: VAGINAL ENGORGEMENT AND CLITORAL ERECTILE INSUFFICIENCY SYNDROMES", INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH,GB,STOCKTON, BASINGSTOKE, vol. 10, no. SUPPL. 02, May 1998 (1998-05-01), pages S84 - S90, XP000853842, ISSN: 0955-9930 * |
PAYNE, ELIZABETH ET AL: "A comparison of prostaglandin E-2 vaginal tablets with vaginal gel for ripening the unfavourable cervix and induction of labour.", JOURNAL OF OBSTETRICS AND GYNAECOLOGY (ABINGDON), (1993) VOL. 13, NO. 2, PP. 103-106., XP000997664 * |
QURESHI, AASIM: "Vasomax Zonagen", CURR. OPIN. CENT. PERIPHER. NERV. SYST. INVEST. DRUGS (1999), 1(2), 262-267, XP000989426 * |
ZORGNIOTTI A W: "EXPERIENCE WITH BUCCAL PHENTOLAMINE MESYLATE FOR IMPOTENCE", INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH,GB,STOCKTON, BASINGSTOKE, vol. 6, no. 1, 1 March 1994 (1994-03-01), pages 37 - 41, XP000653737, ISSN: 0955-9930 * |
Also Published As
Publication number | Publication date |
---|---|
CN1374861A (en) | 2002-10-16 |
EP1220666A2 (en) | 2002-07-10 |
JP2002541100A (en) | 2002-12-03 |
MXPA01010021A (en) | 2002-07-30 |
NO20014827D0 (en) | 2001-10-04 |
BR0009583A (en) | 2002-06-11 |
AU4203600A (en) | 2000-10-23 |
WO2000059491A2 (en) | 2000-10-12 |
NO20014827L (en) | 2001-12-04 |
CA2366903A1 (en) | 2000-10-12 |
KR20020015310A (en) | 2002-02-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1177190B1 (en) | USE OF SELECTIVE ANTAGONISTS OF THE ALPHA 1b-ADRENERGIC RECEPTOR FOR IMPROVEMENT OF SEXUAL DYSFUNCTION | |
KR20110036583A (en) | 6-1h-imidazo-quinazoline and quinolines derivatives, new mao inhibitors and imidazoline receptor ligands | |
NO20053582L (en) | Benzoazolylpiperazine derivatives having VRI antagonist activity. | |
KR20040048995A (en) | Quinoline compound | |
JP2003506347A5 (en) | ||
NO20032208D0 (en) | Benzodiazepine derivatives as GABA A receptor modulators | |
WO2001064645A3 (en) | Derivatives of quinoline as alpha-2 antagonists | |
IL148932A0 (en) | INHIBITORS OF αLβ2 MEDIATED CELL ADHESION | |
KR100226954B1 (en) | Piperidinyl benzimidazole derivatives, the pharmaceutical composition containing them and the process of them | |
TR200200263T2 (en) | New selective retinoid agonists | |
WO2000059491A3 (en) | Methods for modulating the human sexual response | |
TR200000720T2 (en) | Method for the synthesis of quinoline derivatives. | |
DK1309562T3 (en) | 4-Alkoxycyclohexane-1-aminocarboxylic acid esters and process for their preparation | |
Reimann et al. | A convenient synthesis of 1-benzyl-1, 2, 3, 4-tetrahydroisoquinolines by combined Strecker/Bruylants reaction | |
ATE399164T1 (en) | ANTAGONISTS OF THE OPIOID RECEPTOR | |
BR0209901A (en) | Processes for the synthesis of 2,3-dihydro-1,4-dioxino- [2,3-f] quinoline derivatives | |
DZ3119A1 (en) | New derivatives of n-triazolylmethyl-piperazines as neurokinin receptor antagonists. | |
HU211554A9 (en) | Circulation-active dibenzo/1,5/dioxocin-5-ones | |
PE20030327A1 (en) | 3-5-DIHYDROXY-2,2-DIMETHYL-VALERONITRILS PROTECTED FOR THE SYNTHESIS OF EPOTILONES AND THEIR DERIVATIVES AND METHOD FOR THEIR OBTAINMENT | |
DK1102765T3 (en) | Process for the synthesis of (1H) -benzo [c] quinolizin-3-one derivatives | |
NO20024198D0 (en) | Process for the preparation of citalopram | |
KR100856141B1 (en) | Benzazepine derivatives as mao-b inhibitors | |
KR20060125000A (en) | 3,4-dihydroisoquinolinium salt derivatives | |
TR200401864T4 (en) | Process for preparing quinolylacrylonitrile and its intermediates | |
DK1347960T3 (en) | Process for the preparation of (+/-) trans-4-p-fluorophenyl-3-hydromethyl-1-methylpiperidine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 00807879.3 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AU BR CA CN ES IL JP KR MX NO NZ US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
ENP | Entry into the national phase |
Ref document number: 2366903 Country of ref document: CA Ref document number: 2366903 Country of ref document: CA Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2001/010021 Country of ref document: MX Ref document number: 1020017012674 Country of ref document: KR |
|
ENP | Entry into the national phase |
Ref document number: 2000 609055 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000921760 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 515296 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09937879 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 2000921760 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2000921760 Country of ref document: EP |